NeuBase Therapeutics (NBSE) Q1 2023 Earnings

11MayConfirmed
Aug 22
Dec 22
Q4 2022
Q1 2023
-0.3
-0.24
-0.17
-0.11

Details

Expected EPS
-0.11
Actual EPS
-0.12
Surprise EPS
-0.01
Surprise Percent
+9.09%

Description

NeuBase Therapeutics (NBSE) has reported earnings of -0.12 per share for Q1 2023.

0 Comments

Share your thoughts